IN2012DN00640A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN00640A IN2012DN00640A IN640DEN2012A IN2012DN00640A IN 2012DN00640 A IN2012DN00640 A IN 2012DN00640A IN 640DEN2012 A IN640DEN2012 A IN 640DEN2012A IN 2012DN00640 A IN2012DN00640 A IN 2012DN00640A
- Authority
- IN
- India
- Prior art keywords
- variable domains
- hosts
- ligands
- vectors
- compositions
- Prior art date
Links
- 102000009027 Albumins Human genes 0.000 abstract 1
- 108010088751 Albumins Proteins 0.000 abstract 1
- 108060003951 Immunoglobulin Proteins 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 102000018358 immunoglobulin Human genes 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Plant Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22602809P | 2009-07-16 | 2009-07-16 | |
US30755410P | 2010-02-24 | 2010-02-24 | |
PCT/EP2010/060112 WO2011006915A2 (en) | 2009-07-16 | 2010-07-14 | Improved anti-serum albumin binding single variable domains |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN00640A true IN2012DN00640A (zh) | 2015-08-21 |
Family
ID=42829253
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN640DEN2012 IN2012DN00640A (zh) | 2009-07-16 | 2010-07-14 |
Country Status (15)
Country | Link |
---|---|
US (2) | US8679496B2 (zh) |
EP (1) | EP2454285A2 (zh) |
JP (1) | JP2012532620A (zh) |
KR (1) | KR20120038494A (zh) |
CN (1) | CN102574914A (zh) |
AU (1) | AU2010272590B2 (zh) |
BR (1) | BR112012001681A2 (zh) |
CA (1) | CA2768462A1 (zh) |
EA (1) | EA201270174A1 (zh) |
IL (1) | IL217520A0 (zh) |
IN (1) | IN2012DN00640A (zh) |
MX (1) | MX2012000765A (zh) |
SG (1) | SG177601A1 (zh) |
WO (1) | WO2011006915A2 (zh) |
ZA (1) | ZA201200276B (zh) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010094720A2 (en) * | 2009-02-19 | 2010-08-26 | Glaxo Group Limited | Improved anti-tnfr1 polypeptides, antibody variable domains & antagonists |
BR112012001681A2 (pt) * | 2009-07-16 | 2019-09-24 | Graxo Group Ltd | domínios variáveis de ligação de anti-albumina sérica aperfeiçoados |
US9012609B2 (en) | 2010-08-13 | 2015-04-21 | Glaxosmithkline Intellectual Property Development Limited | Anti-serum albumin binding variants |
EP2646467A2 (en) * | 2010-12-01 | 2013-10-09 | Glaxo Group Limited | Improved anti-serum albumin binding single variable domains |
PL2776466T3 (pl) | 2011-11-11 | 2018-01-31 | Ucb Biopharma Sprl | Przeciwciała wiążące albuminę i ich fragmenty wiążące |
GB201200563D0 (en) * | 2012-01-13 | 2012-02-29 | Imp Innovations Ltd | Binding molecule |
US20190023809A1 (en) * | 2015-09-03 | 2019-01-24 | The Children's Mercy Hospital | Anti-nicotinamide phosphoribosyltransferase antibody genes and methods of use thereof |
NO2768984T3 (zh) | 2015-11-12 | 2018-06-09 | ||
CN108290943A (zh) * | 2015-11-13 | 2018-07-17 | 埃博灵克斯股份有限公司 | 改进的血清白蛋白结合免疫球蛋白可变结构域 |
EA201891165A1 (ru) | 2015-11-18 | 2018-11-30 | Мерк Шарп И Доум Корп. | Молекулы, связывающие pd1 и/или lag3 |
AU2016355569B2 (en) | 2015-11-18 | 2020-01-02 | Merck Sharp & Dohme Llc | CTLA4 binders |
US11332519B2 (en) | 2015-11-18 | 2022-05-17 | Ablynx N.V. | Serum albumin binders |
RU2755724C2 (ru) | 2015-11-18 | 2021-09-20 | Мерк Шарп И Доум Корп. | Pd1/ctla4-связывающие вещества |
IL310340A (en) * | 2016-12-07 | 2024-03-01 | Ablynx Nv | Immunoglobulin sites with a single variable enhance serum albumin binding |
BR112019014599A2 (pt) * | 2017-01-17 | 2020-03-03 | Ablynx N.V. | Ligantes de albumina sérica melhorados |
JP7300385B2 (ja) | 2017-01-17 | 2023-06-29 | アブリンクス エン.ヴェー. | 改善された血清アルブミン結合剤 |
CN118403180A (zh) | 2017-02-16 | 2024-07-30 | 索纳特生物疗法公司 | 白蛋白结合结构域融合蛋白 |
MX2020003562A (es) | 2017-10-10 | 2020-10-01 | Numab Therapeutics AG | Anticuerpo multiespecifico. |
EP3470426A1 (en) | 2017-10-10 | 2019-04-17 | Numab Therapeutics AG | Multispecific antibody |
TW202045545A (zh) * | 2019-02-22 | 2020-12-16 | 美商安維塔生物科學股份有限公司 | 白蛋白結合抗體及其用途 |
EP3816185A1 (en) | 2019-11-04 | 2021-05-05 | Numab Therapeutics AG | Multispecific antibody directed against pd-l1 and a tumor-associated antigen |
GB201919061D0 (en) | 2019-12-20 | 2020-02-05 | Ucb Biopharma Sprl | Multi-specific antibody |
EP4133084A1 (en) | 2020-04-09 | 2023-02-15 | Autolus Limited | Polypeptide |
GB202007441D0 (en) | 2020-05-19 | 2020-07-01 | Autolus Ltd | Polypeptide |
EP3915580A1 (en) | 2020-05-29 | 2021-12-01 | Numab Therapeutics AG | Multispecific antibody |
EP3988568A1 (en) | 2020-10-21 | 2022-04-27 | Numab Therapeutics AG | Combination treatment |
AU2021395729A1 (en) | 2020-12-07 | 2023-07-13 | UCB Biopharma SRL | Multi-specific antibodies and antibody combinations |
WO2022167460A1 (en) | 2021-02-02 | 2022-08-11 | Numab Therapeutics AG | Multispecific antibodies having specificity for ror1 and cd3 |
EP4183800A1 (en) | 2021-11-19 | 2023-05-24 | Medizinische Hochschule Hannover | Novel sars-cov-2 neutralizing antibodies |
WO2024038095A1 (en) | 2022-08-16 | 2024-02-22 | Iome Bio | NOVEL ANTI-RGMb ANTIBODIES |
WO2024170756A1 (en) | 2023-02-17 | 2024-08-22 | Ablynx N.V. | Polypeptides binding to the neonatal fc receptor |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL127127A0 (en) | 1998-11-18 | 1999-09-22 | Peptor Ltd | Small functional units of antibody heavy chain variable regions |
JP2005500034A (ja) * | 2001-06-20 | 2005-01-06 | プロション バイオテク リミテッド | 受容体型タンパク質チロシンキナーゼ活性化を遮断する抗体、そのスクリーニング方法、及びその使用 |
US20100081792A1 (en) * | 2001-06-28 | 2010-04-01 | Smithkline Beecham Corporation | Ligand |
US9321832B2 (en) * | 2002-06-28 | 2016-04-26 | Domantis Limited | Ligand |
CN1678634A (zh) | 2002-06-28 | 2005-10-05 | 多曼蒂斯有限公司 | 免疫球蛋白单个变体抗原结合区及其特异性构建体 |
SI1737962T1 (sl) | 2004-03-24 | 2011-01-31 | Domantis Ltd | Univerzalni signalni peptid GAS1 |
EP1784427A2 (en) | 2004-06-01 | 2007-05-16 | Domantis Limited | Bispecific fusion antibodies with enhanced serum half-life |
US7563443B2 (en) * | 2004-09-17 | 2009-07-21 | Domantis Limited | Monovalent anti-CD40L antibody polypeptides and compositions thereof |
CN101128487B (zh) | 2004-12-02 | 2012-10-10 | 杜门蒂斯有限公司 | 靶向血清白蛋白和glp-1或pyy的双特异性结构域抗体 |
GB0521621D0 (en) * | 2005-10-24 | 2005-11-30 | Domantis Ltd | Tumor necrosis factor receptor 1 antagonists for treating respiratory diseases |
BRPI0619225A2 (pt) * | 2005-12-01 | 2017-11-07 | Domantis Ltd | monômero de anticorpo de domínio, ligando, ácidos nucleicos isolado e recombinante, vetor, célula hospedeira, método para produzir um monômero de dab de ligando, composição farmacêutica, dispositivo de liberação de medicamento, uso de um monômero de anticorpo de domínio, e, método para tratar uma doença inflamatória, artrite ou doença respiratória |
EP1957537A2 (en) * | 2005-12-01 | 2008-08-20 | Domantis Limited | Competitive domain antibody formats that bind interleukin 1 receptor type 1 |
EA013878B1 (ru) * | 2005-12-06 | 2010-08-30 | Домантис Лимитед | Лиганды, имеющие специфичность связывания в отношении рецептора эпидермального фактора роста (egfr) и/или сосудистого эндотелиального фактора роста (vegf), и способы их применения |
WO2007085815A2 (en) * | 2006-01-24 | 2007-08-02 | Domantis Limited | Ligands that bind il-4 and/or il-13 |
CA2640066A1 (en) | 2006-01-24 | 2007-08-02 | Roland Beckmann | Fusion proteins that contain natural junctions |
CA2688434A1 (en) | 2007-06-06 | 2008-12-11 | Domantis Limited | Polypeptides, antibody variable domains and antagonists |
WO2009149143A1 (en) * | 2008-06-03 | 2009-12-10 | E. I. Du Pont De Nemours And Company | Adhesion of polyamides to epoxy resins |
US8906035B2 (en) * | 2008-06-04 | 2014-12-09 | Ethicon Endo-Surgery, Inc. | Endoscopic drop off bag |
US10198891B2 (en) * | 2008-06-06 | 2019-02-05 | Epona Llc | System and method for regulating fuel transactions |
JP6067221B2 (ja) * | 2008-06-06 | 2017-01-25 | ダニスコ・ユーエス・インク | 微生物プロテアーゼ変異種を含有する組成物と方法 |
BR112012001681A2 (pt) * | 2009-07-16 | 2019-09-24 | Graxo Group Ltd | domínios variáveis de ligação de anti-albumina sérica aperfeiçoados |
-
2010
- 2010-07-14 BR BR112012001681A patent/BR112012001681A2/pt not_active IP Right Cessation
- 2010-07-14 JP JP2012520016A patent/JP2012532620A/ja active Pending
- 2010-07-14 CA CA2768462A patent/CA2768462A1/en not_active Abandoned
- 2010-07-14 SG SG2012001855A patent/SG177601A1/en unknown
- 2010-07-14 AU AU2010272590A patent/AU2010272590B2/en not_active Ceased
- 2010-07-14 CN CN2010800414331A patent/CN102574914A/zh active Pending
- 2010-07-14 IN IN640DEN2012 patent/IN2012DN00640A/en unknown
- 2010-07-14 MX MX2012000765A patent/MX2012000765A/es not_active Application Discontinuation
- 2010-07-14 KR KR1020127003939A patent/KR20120038494A/ko not_active Application Discontinuation
- 2010-07-14 EA EA201270174A patent/EA201270174A1/ru unknown
- 2010-07-14 WO PCT/EP2010/060112 patent/WO2011006915A2/en active Application Filing
- 2010-07-14 US US13/384,316 patent/US8679496B2/en not_active Expired - Fee Related
- 2010-07-14 EP EP10734965A patent/EP2454285A2/en not_active Withdrawn
-
2012
- 2012-01-12 IL IL217520A patent/IL217520A0/en unknown
- 2012-01-13 ZA ZA2012/00276A patent/ZA201200276B/en unknown
-
2014
- 2014-01-30 US US14/168,168 patent/US20140140996A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2010272590A1 (en) | 2012-02-02 |
US8679496B2 (en) | 2014-03-25 |
SG177601A1 (en) | 2012-02-28 |
WO2011006915A3 (en) | 2011-03-03 |
EA201270174A1 (ru) | 2012-07-30 |
CA2768462A1 (en) | 2011-01-20 |
WO2011006915A2 (en) | 2011-01-20 |
IL217520A0 (en) | 2012-02-29 |
AU2010272590B2 (en) | 2013-10-10 |
KR20120038494A (ko) | 2012-04-23 |
BR112012001681A2 (pt) | 2019-09-24 |
MX2012000765A (es) | 2012-02-13 |
US20140140996A1 (en) | 2014-05-22 |
ZA201200276B (en) | 2012-09-26 |
JP2012532620A (ja) | 2012-12-20 |
EP2454285A2 (en) | 2012-05-23 |
US20120114647A1 (en) | 2012-05-10 |
CN102574914A (zh) | 2012-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2012DN00640A (zh) | ||
MX2011008752A (es) | Variantes de union a anti-albumina de suero mejoradas. | |
MX2012013406A (es) | Variantes de union mejoradas anti-albumina serica. | |
MX2011008749A (es) | Variantes de union a anti-albumina de suero mejoradas. | |
CY1119567T1 (el) | Θεραπευτικα πεπτιδια | |
WO2012072731A3 (en) | Improved anti-serum albumin binding single variable domains | |
WO2014083208A9 (en) | Binding proteins comprising at least two repeat domains against her2 | |
MX2012003939A (es) | Fusiones y conjugados de farmaco. | |
MX2015011075A (es) | Peptidos terapeuticos. | |
WO2013072813A3 (en) | Cytotoxic peptides and antibody drug conjugates thereof | |
WO2013130683A3 (en) | Xten conjugate compositions and methods of making same | |
UA110370C2 (en) | Conjugates of amatoxin with improved linkages | |
WO2011123820A3 (en) | Single isomeric conjugates of rhodamine dyes | |
WO2011086143A3 (en) | Liver targeting domain antibodies | |
UA106900C2 (uk) | Агоністичний dr5-зв'язувальний поліпептид | |
MX2013002055A (es) | Variantes anti-enlace de albumina de suero mejodas. | |
WO2011112566A3 (en) | Basigin binding proteins | |
CA3036643C (en) | Cmet monoclonal binding agents, drug conjugates thereof and uses thereof | |
MX2015014198A (es) | Anticuerpos cuyo objetivo es m-csf. | |
WO2014044793A3 (en) | Cd22-binding peptides | |
WO2008005470A3 (en) | Polypeptides that bind membrane proteins | |
EP2569327A4 (en) | EIF4E BINDING PEPTIDES | |
MX2016008478A (es) | Nuevo anticuerpo anti adam17 y su uso en el tratamiento del cancer. | |
WO2016005474A8 (en) | Site selective conjugation of an oligonucleotide conjugate or a small molecule to a metal binding protein | |
CR20110473A (es) | Variantes de union a anti-albúmina de suero mejoradas. |